Uppsala, Sweden, 18th September 2017 – Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction plates with an integral Hydrolysis capability that enable chemists to perform sample hydrolysis within the extraction plate; saving time and reducing sample transfer issues.

EVOLUTE® HYDRO Solid Phase Extraction plates gives customers the ability to perform sample (typically urine) hydrolysis within the wells of the extraction plate, followed directly by sample clean up using solid phase extraction, without the need for sample transfer. The Hydro frit technology used by the plates reliably “holds up” both sample and enzyme during incubation at elevated temperatures. This reduces clogging during subsequent clean up steps, leading to robust and streamlined sample preparation. Sample clean-up is performed in the same plate, without the need to transfer samples, saving time and reducing risky sample handling steps.

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in South Korea, China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 308 employees, with sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com

About Biotage

Biotage is a global Life Science company that develops innovative and effective solutions for separation within organic and analytical chemistry, as well as for industrial applications. Biotage is listed on NASDAQ Stockholm.